The ASM sent a letter to Senator Tom Harkin thanking him for the Accelerating Biomedical Research Act and his leadership regarding funding for the National Institutes of Health.
ASM provided comments to the Centers for Medicare & Medicaid Services (CMS) regarding Section 1834A, “Improving Policies for Clinical Diagnostic Laboratory Tests,” added to the Social Security Law by the Protecting Access to Medicare Act of 2014 (PAMA).
The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2015 Clinical Laboratory Fee Schedule.
The June issue of the Clinical Microbiology Issues Update has been published by the Office of Public Affairs.
The content of this page is restricted to ASM Members only.
Please login at the top-right or to become a member, join ASM.
The ASM sent a letter to the House Science, Space and Technology Committee regarding the DOE authorization bill that would make significant cuts in R&D funding for the energy and environmental sciences.
The ASM joined 50 other organizations in a campaign to highlight Closing the Innovation Deficit.
Presentations from the breakfast are now available.
The ASM sent a letter to Senator Richard Durbin (D-IL) endorsing the bill which would create a trust fund to support a mandatory funding stream for biomedical research supported by the National Institutes of Health and other federal agencies involved in biomedical research.
The ASM Office of Public Affairs has summarized the President's FY 2015 budget for the agencies that fund research and public health programs and has developed a chart highlighting proposed funding levels for the federal agencies and programs of importance to microbiology and the ASM membership.
The ASM submitted a letter to the Senate Committee on Homeland Security and Governmental Affairs as part of the hearing record for its January 14 hearing entitled “Examining Conference and Travel Spending Across the Federal Government.”